http://www.fpnotebook.com/
Implanon
- Definition
- Subcutaneous inserted Progestin containing rod
- Background
- Duration: Continuous Contraception for 3 years
- Progestin: Etonogestrel
- Release rate
- Initial: 60-70 mcg/day
- Tapers to 30 mcg/day
- Rod dimensions: (Lenth: 40 mm, Diameter 2 mm)
- Efficacy
- Failure rate: 1 per 1000 users
- Failure rate may be higher if >130% of Ideal Weight
- Several medications lower efficacy (see below)
- Failure rate: 1 per 1000 users
- Drug Interactions: Medications that lower efficacy
- Phenobarbital and other barbiturates
- Phenytoin, Fosphenytoin and other Hydantoins
- Carbamazepine
- Griseofulvin
- Protease Inhibitors
- Primidone
- Safety
- Adverse effects
- Weight gain
- Acne Vulgaris
- Depression or Emotional lability
- Irregular Menstrual Bleeding
- Amenorrhea most common
- Menorrhagia
- Bleeding 50% less with Doxycycline 100 bid x5 days
- Weisberg (2006) Human Reproduction 21:295
- Procedure: Insertion (<5 minutes)
- No incision needed
- Implanon comes inn preloaded applicator
- Inserted into subcutaneous skin of arm
- Both patient and physician must palpate rod post-insert
- Procedure: Removal (<10 minutes)
- Infiltrate local anesthetic under Implanon
- Incision of 2-3 mm at distal tip of implanon
- Implanon pushed from proximal end into incision
- Make incision through fibrous sheeth around implanon
- Remove by grasping Implanon rod with forceps
- Image with ultrasound if device cannot be palpated
- References
- Welsh (2006) New Contraceptives, Lecture, Wyoming, MN
- Funk (2005) {a 8122} 71:319
Implanon (C0673606) | |
|---|---|
| Concepts | Steroid (T110) , Pharmacologic Substance (T121) |
| MSH | C044815 |
| English | Implanon, Nourypharma brand of 3-keto-desogestrel, Organon brand of 3-keto-desogestrel |
| Sources | MSH, NCI, RXNORM Derived from the NIH UMLS (Unified Medical Language System) |